A Post-marketing Surveillance Study of Beyfortus (Nirsevimab) in Republic of Korea
A Post-marketing Surveillance Study of Beyfortus (Nirsevimab) in Republic of Korea
Recruiting · NCT07200206 · Registry updated 2025-12-03Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Post-marketing Surveillance Study of Beyfortus (Nirsevimab) in Republic of Korea | Respiratory Syncytial Virus | Recruiting | Not stated | 2025-12-03 | NCT07200206 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Sanofi | 254 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Nam Seung Woo Pediatric: 4100007 | Hwaseong-si, Gyeonggi-do | South Korea | 1 |